These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5148781)

  • 21. [Significance of cholinesterase; pharmacological activity of a specific inhibitor of true cholinesterase: CT-3318].
    ZANDA CE
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1445-7. PubMed ID: 13446082
    [No Abstract]   [Full Text] [Related]  

  • 22. Barbiturates in newborn animals: a drug response problem.
    Halevy S; Orkin LR
    Clin Anesth; 1974; 10(2):157-62. PubMed ID: 4590559
    [No Abstract]   [Full Text] [Related]  

  • 23. [Determination of the development of psychotic dependence to drugs in small animals. 4. Selective drinking of barbital and ethanol solutions by mice].
    Kosaka N; Kaneto H
    Yakubutsu Seishin Kodo; 1982 Dec; 2(2):61-8. PubMed ID: 6892351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine.
    Chaney LA; Rockhold RW; Mozingo JR; Hume AS; Moss JI
    Vet Hum Toxicol; 1997 Aug; 39(4):214-9. PubMed ID: 9251170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of acetone on barbiturate narcosis].
    Postolache V; Safta L; Cuparencu B; Steiner L
    Arch Toxikol; 1969; 24(3):333-7. PubMed ID: 5360668
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the mechanism of potentiation of hexenal narcosis by ortho-tolylhydrazide of diethylglycolic acid].
    Bargteĭl BA; Kolla VE
    Farmakol Toksikol; 1969; 32(2):141-3. PubMed ID: 5772134
    [No Abstract]   [Full Text] [Related]  

  • 27. [Some differences in the effects of anticholinesterase compounds on nicotine and arecoline sensitivity in mice and rabbits].
    Erkova AI; Savateev NV; Sofronov GA; Sherstobitov OE
    Dokl Akad Nauk SSSR; 1966 Apr; 167(5):1197-200. PubMed ID: 5996472
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of cross-tolerance between barbiturates and phencyclidine.
    Flint BA; Ho IK
    Subst Alcohol Actions Misuse; 1980; 1(3):287-93. PubMed ID: 7347920
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of cholinesterase inhibition by in vitro manifestation of various effects of a specific inhibitor, bis(2,3-dihydro-2-piperidinomethy1-5-benzofuranyl) ketone dimethiodide (CT-3318)].
    ZANDA CE
    Arch Int Pharmacodyn Ther; 1959 May; 120(1):53-63. PubMed ID: 13662037
    [No Abstract]   [Full Text] [Related]  

  • 30. Reappraisal of the barbiturate sleeping time in mice as predictive tool for the detection of liver enzymes inhibiting drugs.
    André P; Descotes J; Simonet R; Evreux JC
    Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):695-9. PubMed ID: 6530908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 32. [Unexpected interactions of some psychotropic drugs with barbital and pentobarbital effects in mice (author's transl)].
    Simon P; Chermat R; Doaré L; Bourin M; Farinotti R
    J Pharmacol; 1982; 13(2):241-52. PubMed ID: 7098486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of the structure-activity correlations within a series of ambenonium analogs.
    LANDS AM; HOPPE JO; ARNOLD A; KIRCHNER FK
    J Pharmacol Exp Ther; 1958 Jun; 123(2):121-7. PubMed ID: 13550066
    [No Abstract]   [Full Text] [Related]  

  • 34. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol].
    Avakumov VM; Batulin IuM
    Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of some cholinomimetic and cholinolytic drugs on halothane shivering in mice.
    Nikki P
    Ann Med Exp Biol Fenn; 1968; 46(4):521-30. PubMed ID: 5731565
    [No Abstract]   [Full Text] [Related]  

  • 37. [Spinal anesthesia in barbiturate-induced sleep: synergism of accumulation or of potentiation?].
    Matossi L'Orsa R; Boaro G
    Minerva Anestesiol; 1967 Jan; 33(1):2-4. PubMed ID: 5596005
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice.
    Sansone M; Battaglia M; Pavone F
    Funct Neurol; 1995; 10(4-5):163-7. PubMed ID: 8749042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Limits of therapy with oximes in poisoning with insecticidal alkylphosphates].
    Zech R; Erdmann WD; Engelhard H
    Arzneimittelforschung; 1967 Sep; 17(9):1196-202. PubMed ID: 5632298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Counterindications of various drugs in bronchial asthma].
    Bruchhausen D; Haschem J
    Med Welt; 1969 Dec; 49():2666-8. PubMed ID: 5379525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.